View in EDS HTML Full Text PDF Full Text

Implications and prognostic impact of mass spectrometry in patients with newly-diagnosed multiple myeloma.

Saved in:
Bibliographic Details
Title: Implications and prognostic impact of mass spectrometry in patients with newly-diagnosed multiple myeloma.
Authors: Mai EK; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany., Huhn S; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.; National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg, Germany., Miah K; Division of Biostatistics, German Cancer Research Center (DKFZ), Heidelberg, Germany., Poos AM; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany., Scheid C; Department of Internal Medicine I, University Hospital Cologne, Cologne, Germany., Weisel KC; Department of Oncology, Hematology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Bertsch U; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.; National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg, Germany., Munder M; Department of Internal Medicine III, University Medical Center Mainz, Mainz, Germany., Berlanga O; The Binding Site Group Ltd, Birmingham, United Kingdom., Hose D; Department of Hematology and Immunology, Myeloma Center Brussels, Vrije Universiteit Brussel, Brussels, Belgium., Seckinger A; Department of Hematology and Immunology, Myeloma Center Brussels, Vrije Universiteit Brussel, Brussels, Belgium., Jauch A; Institute of Human Genetics, University of Heidelberg, Heidelberg, Germany., Blau IW; Medical Clinic, Charité University Medicine Berlin, Berlin, Germany., Hänel M; Department of Internal Medicine III, Klinikum Chemnitz, Chemnitz, Germany., Salwender HJ; Asklepios Tumorzentrum Hamburg, AK Altona and AK St. Georg, Hamburg, Germany., Benner A; Division of Biostatistics, German Cancer Research Center (DKFZ), Heidelberg, Germany., Raab MS; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany., Goldschmidt H; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.; National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg, Germany., Weinhold N; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany. niels.weinhold@med.uni-heidelberg.de.
Source: Blood cancer journal [Blood Cancer J] 2023 Jan 04; Vol. 13 (1), pp. 1. Date of Electronic Publication: 2023 Jan 04.
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36599831
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Implications and prognostic impact of mass spectrometry in patients with newly-diagnosed multiple myeloma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Mai+EK%22">Mai EK</searchLink>; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Huhn+S%22">Huhn S</searchLink>; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.; National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Miah+K%22">Miah K</searchLink>; Division of Biostatistics, German Cancer Research Center (DKFZ), Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Poos+AM%22">Poos AM</searchLink>; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Scheid+C%22">Scheid C</searchLink>; Department of Internal Medicine I, University Hospital Cologne, Cologne, Germany.<br /><searchLink fieldCode="AU" term="%22Weisel+KC%22">Weisel KC</searchLink>; Department of Oncology, Hematology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.<br /><searchLink fieldCode="AU" term="%22Bertsch+U%22">Bertsch U</searchLink>; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.; National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Munder+M%22">Munder M</searchLink>; Department of Internal Medicine III, University Medical Center Mainz, Mainz, Germany.<br /><searchLink fieldCode="AU" term="%22Berlanga+O%22">Berlanga O</searchLink>; The Binding Site Group Ltd, Birmingham, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Hose+D%22">Hose D</searchLink>; Department of Hematology and Immunology, Myeloma Center Brussels, Vrije Universiteit Brussel, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Seckinger+A%22">Seckinger A</searchLink>; Department of Hematology and Immunology, Myeloma Center Brussels, Vrije Universiteit Brussel, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Jauch+A%22">Jauch A</searchLink>; Institute of Human Genetics, University of Heidelberg, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Blau+IW%22">Blau IW</searchLink>; Medical Clinic, Charité University Medicine Berlin, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Hänel+M%22">Hänel M</searchLink>; Department of Internal Medicine III, Klinikum Chemnitz, Chemnitz, Germany.<br /><searchLink fieldCode="AU" term="%22Salwender+HJ%22">Salwender HJ</searchLink>; Asklepios Tumorzentrum Hamburg, AK Altona and AK St. Georg, Hamburg, Germany.<br /><searchLink fieldCode="AU" term="%22Benner+A%22">Benner A</searchLink>; Division of Biostatistics, German Cancer Research Center (DKFZ), Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Raab+MS%22">Raab MS</searchLink>; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Goldschmidt+H%22">Goldschmidt H</searchLink>; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.; National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Weinhold+N%22">Weinhold N</searchLink>; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany. niels.weinhold@med.uni-heidelberg.de.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101568469%22">Blood cancer journal</searchLink> [Blood Cancer J] 2023 Jan 04; Vol. 13 (1), pp. 1. <i>Date of Electronic Publication: </i>2023 Jan 04.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101568469 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2044-5385 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220445385%22">20445385 </searchLink><i>NLM ISO Abbreviation: </i>Blood Cancer J <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36599831
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41408-022-00772-9
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1
    Titles:
      – TitleFull: Implications and prognostic impact of mass spectrometry in patients with newly-diagnosed multiple myeloma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Mai EK
      – PersonEntity:
          Name:
            NameFull: Huhn S
      – PersonEntity:
          Name:
            NameFull: Miah K
      – PersonEntity:
          Name:
            NameFull: Poos AM
      – PersonEntity:
          Name:
            NameFull: Scheid C
      – PersonEntity:
          Name:
            NameFull: Weisel KC
      – PersonEntity:
          Name:
            NameFull: Bertsch U
      – PersonEntity:
          Name:
            NameFull: Munder M
      – PersonEntity:
          Name:
            NameFull: Berlanga O
      – PersonEntity:
          Name:
            NameFull: Hose D
      – PersonEntity:
          Name:
            NameFull: Seckinger A
      – PersonEntity:
          Name:
            NameFull: Jauch A
      – PersonEntity:
          Name:
            NameFull: Blau IW
      – PersonEntity:
          Name:
            NameFull: Hänel M
      – PersonEntity:
          Name:
            NameFull: Salwender HJ
      – PersonEntity:
          Name:
            NameFull: Benner A
      – PersonEntity:
          Name:
            NameFull: Raab MS
      – PersonEntity:
          Name:
            NameFull: Goldschmidt H
      – PersonEntity:
          Name:
            NameFull: Weinhold N
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 04
              M: 01
              Text: 2023 Jan 04
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 2044-5385
          Numbering:
            – Type: volume
              Value: 13
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Blood cancer journal
              Type: main
ResultId 1